ppje10k123107.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
10-K
x Annual Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
For the
Fiscal Year Ended December 31,
2007
o Transition Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
For the
transition period from ________________ to ________________
Commission
File No.
000-50014
PPJ
ENTERPRISE, INC.
(Exact
name of registrant as specified in its charter)
Nevada
(State
or other jurisdiction of incorporation or organization)
|
|
80-0478644
(I.R.S.
Employer Identification No.)
|
1105
Terminal Way, Suite 202, Reno, NV 89502
(Address
of principal executive offices)
Registrant's
telephone number, including area code: (775)
348-5735
Securities
Registered Pursuant to Section 12(b) of the Act: None
Title
of each class
|
|
Name
of each exchange
On
which registered
|
(None)
|
|
(None)
|
Securities
Registered Pursuant to Section 12(g) of the Act:
None
Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in
Rule 405 of the Securities Act. Yes o
No x
Indicate
by check mark if the registrant is not required to file reports pursuant to
Section 13 or Section 15(d) of the Exchange Act. Yes o
No x
Indicate
by check mark whether the registrant (1) has filed all reports required to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing requirements for
the past 90 days. Yes x
No o
Indicate
by check mark if disclosure of delinquent filers pursuant to Item 405 of
Regulation S-K is not contained herein, and will not be contained, to the best
of registrant's knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form 10-K. o
Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting company. See
the definitions of "large accelerated filer," "accelerated filer" and "smaller
reporting company" in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
o Accelerated filer o Non-accelerated filer o Smaller reporting company x
Indicate
by check mark whether the registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act). Yes o
No x
The
aggregate market value of voting and non-voting common equity held by
non-affiliates of the registrant on December 31, 2007 was
$50,000.00.
The
number of shares outstanding of the registrant's common stock on December 31,
2007 was as follows: 177,302,000 shares.
Documents
Incorporated by Reference: NONE
Transitional
Small Business Disclosure Format: Yes o No x
HEALTHCARE
BUSINESS SERVICES GROUPS, INC.
FORM
10-KSB
YEAR
ENDED DECEMBER 31, 2007
INDEX
|
Part
I
|
|
|
|
|
Item
1.
|
Description
of Business
|
4
|
|
|
|
Item
2.
|
Description
of Property
|
6
|
|
|
|
Item
3.
|
Legal
Proceedings
|
6
|
|
|
|
|
Part
II
|
|
|
|
|
Item
5.
|
Market
for Common Equity and Related Stockholder Matters
|
7
|
|
|
|
Item
6.
|
Management's
Discussion and Analysis or Plan of Operation
|
7
|
|
|
|
Item
7.
|
Financial
Statements
|
11
|
|
|
|
Item
8.
|
Changes
in and Disagreements with Accountants on Accounting and Financial
Disclosure
|
25
|
|
|
|
Item
8A.
|
Controls
and Procedures
|
25
|
|
|
|
Item
8B. |
Other
Information |
25
|
|
|
|
|
Part
III
|
|
|
|
|
Item
9.
|
Directors,
Executive Officers, Promoters and Control Persons; Compliance with Section
16(a) of the Exchange Act
|
25
|
|
|
|
Item
10.
|
Executive
Compensation
|
26
|
|
|
|
Item
11.
|
Security
Ownership of Certain Beneficial Owners and Management and Related
Stockholder Matters
|
28
|
|
|
|
Item
12.
|
Certain
Relationships and Related Transactions
|
28
|
|
|
|
Item
13.
|
Exhibits
and Reports
|
29
|
|
|
|
|
(a)
Exhibits
|
29
|
|
|
|
Item
14.
|
Principal
Accountant Fees and Services
|
29
|
|
|
|
|
Signatures |
30
|
PART
I
ITEM
1.
|
DESCRIPTION
OF BUSINESS
|
SPECIAL
NOTE REGARDING FORWARD-LOOKING STATEMENTS
Certain
statements in this Annual Report on Form 10-KSB (this "Form 10KSB"), including
statements under "Item 1 Description of Business," and "Item 6 Management's
Discussion and Analysis", constitute "forward looking statements" within the
meaning of Section 27A of the Securities Act of 1934, as amended, and the
Private Securities Litigation Reform Act of 1995 (collectively, the "Reform
Act"). Certain, but not necessarily all, of such forward-looking statements can
be identified by the use of forward-looking terminology such as "believes",
"expects", "may", "should", or "anticipates", or the negative thereof or other
variations thereon or comparable terminology, or by discussions of strategy that
involve risks and uncertainties. Such forward-looking statements involve known
and unknown risks, uncertainties and other factors which may cause the actual
results, performance or achievements of Healthcare Business Services Groups,
Inc. (the Company", "we", "us" or "our") to be materially different from any
future results, performance or achievements expressed or implied by such
forward-looking statements. References in this form 10-KSB, unless another date
is stated, are to December 31, 2007.
BUSINESS
DEVELOPMENT
The
Company was incorporated in the State of Nevada on May 2, 2000, as Winfield
Capital Group, Inc. On June 6, 2001, the Company filed a Certificate of
Amendment to its Articles of Incorporation to affect a name change to "Winfield
Financial Group, Inc." On April 23, 2004, the Company acquired 100% of the
equity interest of Healthcare Business Services Groups, Inc. (“Healthcare”), a
Delaware corporation (“Healthcare”). As part of the same transaction, on May 7,
2004, the Company acquired 100% of the equity interest of AutoMed Software Corp.
("AutoMed"), a Nevada corporation, and 100% of the membership interests of
Silver Shadow Properties, LLC ("Silver Shadow"), a Nevada single member limited
liability company. The transactions are collectively referred to herein as the
"Acquisition”. Prior to the Acquisition, the Company was a business broker,
primarily representing sellers and offering its clients' businesses for sale. As
a result of the Acquisition, the Company changed its business focus to medical
billing.
On
January 7, 2005, the Company filed a Certificate of Amendment to its Articles of
Incorporation, with the Nevada Secretary of State and changed its name to
"Healthcare Business Services Groups, Inc."
On or
about May 7, 2004, the Company acquired Healthcare, AutoMed and Silver Shadow
from Chandana Basu, the sole owner, in exchange for 25,150,000 newly issued
treasury shares of the Company's Common Stock. As a result of the Acquisition,
the Company has changed its business focus. The term "Company" shall include a
reference to PPJ Enterprise (the "Company").
On June
21, 2004, the Company entered into an agreement with Robert Burley (former
Director, President and Chief Executive Officer of the Company) and Linda Burley
(former Director and Secretary of the Company) whereby the Company agreed to
transfer certain assets owned by the Company immediately prior to the change in
control in consideration for Mr. and Mrs. Burley's cancellation of an
aggregate of 2,640,000 of their shares of the Company's common stock. The
Company transferred the following assets to Mr. and Mrs. Burley: (i)
the right to the name "Winfield Financial Group, Inc." and (ii) any contracts,
agreements, rights or other intangible property that related to the Company's
business operations immediately prior to the change in control whether or not
such intangible property was accounted for in the Company's financial
statements. After the issuance of shares to Ms. Basu and the cancellation
of 2,640,000 shares of Mr. and Mrs. Burley's Common Stock, there were
29,774,650 shares of the Company's Common Stock outstanding. As a result of
these transactions, control of the Company shifted to Ms. Basu. At closing,
Ms. Basu owned 25,150,000 shares (or approximately 81%) out of 33,960,150 shares
of the Company's issued and then outstanding Common Stock.
DESCRIPTION
OF THE COMPANY'S CURRENT BUSINESS OPERATIONS
After
acquisition, the Company operated as a medical billing service provider which
attempts to assist various health care providers to enhance their billing
functions. The Company has developed through its subsidiary Automated
Software Corp., a proprietary medical billing software system named AutoMed.
AutoMed was used in house since 2003, after all program bugs cleaned and beta
testing was done for over 2 years prior to launching AutoMed into the market for
commercial distributions. expects that after AutoMed is launched, the Company's
revenues will grow over the next three to five years, as the Company extends its
billing model into the technology era, however, the Company can give no
assurances that it will see increases in revenue.
DESCRIPTION
OF THE COMPANY'S PRINCIPAL PRODUCTS AND SERVICES
The
Company primarily a healthcare support service related company who is dedicated
to help healthcare practices become more efficient and save
money. Due to the over whelming market need the
Company entered into the research, development and now
marketing of its
(1)
proprietary medical billing software ("AutoMed"). AutoMed is a very flexible
automated practice management suite that is a technological innovation by using
OCR/OMR technology to provide healthcare providers a simple and cost effective
way to submit their billing to Governmental payors and insurance companies
without coding, data entry and billing personnel.
(2)
Prepaid collection service – an added line of business
The
Company offers prepaid low cost collection service to healthcare and all other
industries for past due and Bad Debt collection. This is an effective Profit
Recovery program provides an alternative to traditional debt collection
Agencies.
(3)
Healthcare Accounts Receivable Financing – an added line of
business
Medical
factoring, a cash flow solution that speeds up cash flow—allowing payment for
services rendered in days instead of months. Also, provides a one-stop service
for bridge loans, refinancing, asset-based loans, equipment financing,
acquisition financing, revolving lines of credit and accounts receivable
financing. Unlimited and continuous business funding eliminates having to wait
30 to 60 days or longer for invoice payments. Receive factoring funds within 24
to 48 hours – no complicated process—requires only 2 to 5 minutes of
paperwork.
(4)
Healthcare Staffing Solutions – an added line of business
PPJE
offers staffing solutions to fulfill a wide breath of healthcare staffing needs
from the physician office, home care to hospital based.
PPJE
provides a broad range of clinical and medical administrative (including expert
coding, billing and collections to Healthcare management) resources to solve the
most burdensome staffing needs, fulfilling your requirements for highly
qualified staff. All PPJE staff undergoes a stringent process of skills testing,
criminal and OIG/GSA background checks, drug testing, PSHA and HIPAA training,
and reference checks prior to placement.
COMPETITIVE
BUSINESS CONDITIONS
SUBSIDIARY – HEALTHCARE
BUSINESS SERVICES GROUPS, INC. (“Healthcare”).
MEDICAL
BILLING
(A
Delaware Company registered to do business in California during
1997-2008.)
Healthcare
Business Services Groups, Inc. (Delaware Corporation a subsidiary of the Nevada
Company) office was closed in June of 2007 due to lack of funding, Clients
concealing money to resist payments of our fees, loss of clients and excessive
legal fees.
SUBSIDIARY -
AUTOMED
AUTOMATED
MEDICAL BILLING SOFTWARE (A Nevada Company)
“AutoMed”
was initially formed to satisfy its custom medical billing needs. “Healthcare”
began implementing AutoMed in its Medical Billing line of business in July 2003.
“Healthcare” has been using AutoMed since October 2003 for all new medical
billing.
The
“Registrant” intends to promote AutoMed for other aspects of medical office
management as well, as discussed below.
We sold
the first copy of our AutoMed program license in January of 2008 and installed
in March of 2008 into general/internal medical clinic. The program was sold for
39 doctors for a selling price of $230,000. Due to the product being new to the
market, we only installed the program for one physician with initial deposit of
$62,000. We used these funds to customize the program for the clinic, travel,
technical, installation and training. We have received an additional $5,000 in
the second quarter of 2008. There are multiple interests at this point from the
hospital, surgery center and other medical professionals who seek to use AutoMed
program. Additional funding of $2.2 million dollars to effect its business plan
and to promote AutoMed program through out the United States of
America.
DEPENDENCE
ON ONE OR A FEW CUSTOMERS
“Healthcare”
depended on few customers throughout the United States and do not plan to
continue in the medical billing field due to high operational cost. Medical
billing is a very competitive market and competition is almost unlimited. Due to
our higher fees (10%) to perform a customized service to deliver a higher cash
flow to our clients, we have experienced that our clients were the largest
competitors of Healthcare Business Services Groups; Inc itself. Doctors would
sign contracts with us to learn our privileged and specialized method of
billing, once they see a drastic upwards of collections they will change pay to
address to them selves and copy our methods of billing. We have experienced this
conduct over and over again in the recent years. To find new clients,
“Healthcare” spent hundreds of thousands of dollars over the years but the
pattern of conducts we have seen in the recent years by our ex-clients, we were
unable to continue to defend our position which resulted in closing of this
service business. We may consider to résumé our non customized services in the
future into more generalized billing service at lower fees (5-6%). But at this
point the we do not plan to provide billing service..
NEED
FOR GOVERNMENTAL APPROVAL AND THE EFFECTS OF REGULATIONS
Medical
business services are subject to the compliance requirements of the Health
Insurance Portability and Accountability Act ("HIPPA") and the billing
guidelines of the Health Care Financing Administration ("HCFA"). As a result,
Medical Billing and AutoMed are subject to government regulation and government
approval.
RESEARCH
& DEVELOPMENT OVER THE PAST TWO YEARS
The
“Registrant” has spent almost no resource or time during the last two years on
research and development.
EMPLOYEES
The
Company has one full-time employee, Ms. Chandana Basu. Ms. Basu is not a member
of any union in connection with the Company's operations. The Company performs
all its business through consultants on an as needed basis.
ITEM
2.
|
DESCRIPTION
OF PROPERTY
|
The
Company currently leases office space in Reno, Nevada as its corporate address
and performs all interaction through this location. This location is rented on
month to month basis for rent of space and services are as much as
$500.00/mo.
ITEM
3. LEGAL
PROCEEDINGS (Healthcare)
|
“Healthcare”
was a plaintiff to two and defendant to one law suits prior to filing
Bankruptcy. “Healthcare” filed claims for nonpayment of fees by former clients
due to clients diverted funds billed by “Healthcare” and did not pay Billing
fees.
|
On
July 12, 2004, “Healthcare” initiated an arbitration case against Nimish
Shah, M.D. d/b/a New Horizon Medical, Inc. ("New Horizon") v.
“Healthcare”, et al. In connection with arbitration, Healthcare has
claimed against New Horizon the compensatory damages for its fees in the
amount of $75,000 (subject to amendment), prejudgment interest, costs and
attorneys' fees in an unspecified amount. New Horizon has not submitted a
cross-complaint against Healthcare for the breach of contract alleging
that there is substantial discrepancy between the amounts of bills
provided by New Horizon to the Company, for the purpose of securing
payment from various insurance companies, and the funds actually received
from Healthcare. This matter was dismissed by arbitrator for nonpayment of
arbitrator's fee. New Horizon later in 2006, initiated a
lawsuit against “Healthcare” in the Superior Court of California, County
of Los Angeles, Case No. VC 042695, styled New Horizon Medical, this case
is included in Bankruptcy.
|
|
In
January 2004, Claimant Leonard J. Soloniuk, MD initiated an arbitration
against “Healthcare” with the American Arbitration Association, Case No.
72 193 00102 04 TMS, styled Leonard J. Soloniuk, MD v. “Healthcare”. In a
decision dated April 5, 2006, the arbitrator awarded “Healthcare” nothing
against Soloniuk. The arbitrator further awarded Soloniuk $ 275,000
against the “Healthcare” as well as interest accruing from June 1, 2006,
at the rate of ten percent per annum on the unpaid balance. The arbitrator
further ordered “Healthcare” to reimburse Soloniuk costs in the amount of
$ 1,875. “Healthcare” argues that of this $275,000, $210,000 was already
paid to Soloniuk since November 4, 2002, last date of payment were
considered by arbitrator and therefore the judgment should be reduced
accordingly. This case is included in the
Bankruptcy.
|
|
On
November 1, 2007 “Healthcare” filed law suit against Narinder Grewal, MD
for unpaid fees and damages of $3,000,000. Case No. CIVRS706024. Dr.
Grewal filed counter claims. This case is included in the
Bankruptcy.
|
“Healthcare”
and Frank Zondlo, MD agreed to drop their actions against each other. The matter
is included in the Bankruptcy.
Healthcare
is a in a Chapter 7 Bankruptcy protection which was filed on June 26, 2008, case
no. 6:8-Bk-17866. Currently it waits for the 341 creditors meeting. Attorney
David Akintimoye ESQ of Riverside is handling the Chapter 7 case.
From time
to time, we may become party to litigation or other legal proceedings that we
consider to be a part of the ordinary course of our business. Other than the
legal proceedings listed below, we are not currently involved in legal
proceedings that could reasonably be expected to have a material adverse effect
on our business, prospects, financial condition or results of
operations.
PART
II
ITEM
5. MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER
MATTERS
"Bid" and
"Ask" offers for the common stock are listed on the NASDAQ OTC-Bulletin Board
published by the National Quotation Bureau, Inc. below are the high and low bid
prices for the Company's Common Stock for the past two (2) fiscal years. Prior
to January 12, 2005, the Company's trading symbol was "WFLD," however in
connection with the Company's change in business focus and name change; the
Company's securities began trading under the symbol "HBSV" on January 12,
2005.
The
following table sets forth the high and low bid prices for the Company's common
stock for the periods indicated as reported by the NASDAQ OTC-Bulletin Board.
The quotations reflect inter-dealer prices, without retail mark-up, mark-down or
commission and may not represent actual transactions.
There are
90 holders of record of the common stock as of September 19, 2008. The Company
has never paid a cash dividend on its common stock and does not anticipate the
payment of a cash dividend in the foreseeable future. The Company intends to
reinvest in its business operations any funds that could be used to pay a cash
dividend. The Company's common stock is considered a "penny stock" as defined in
the Commission's rules promulgated under the Exchange Act. In general, a
security which is currently quoted on Pink sheets
ITEM
6.
|
MANAGEMENT'S
DISCUSSION AND ANALYSIS OR PLAN OF
OPERATION
|
This
report contains forward looking statements within the meaning of section 27a of
the securities act of 1933, as amended and section 21e of the securities
exchange act of 1934, as amended. The Company's actual results could differ
materially from those set forth on the forward looking statements as a result of
the risks set forth in the company's filings with the Securities and Exchange
Commission, general economic conditions, and changes in the assumptions used in
making such forward looking statements.
On
January 5, 2005, the Registrant changed its name to Healthcare Business Services
Groups, Inc. The Registrant is a holding company for subsidiary “Healthcare”.
The business operations discussed herein are conducted by “Healthcare”. The
Registrant, through “Healthcare”, is engaged in the business of providing
medical billing services to healthcare providers in the United
States.
On
February 14, 2008, the Registrant changed its name to PPJ Enterprise (the
Company) to clear confusion between the Delaware Company and the Nevada Company.
On the same day the Company increased its authorized shares to
1.500,000,000.
On March
21, 2008 PPJE requested change of Ticker Symbol and it is now
(PPJE.PK).
RESULTS
OF OPERATIONS
YEAR
ENDED DECEMBER 31, 2007 COMPARED TO YEAR ENDED DECEMBER 31, 2006
Healthcare
Business Services Groups, Inc. (Delaware Corporation a subsidiary of the Nevada
Company) office was closed in June of 2007 due to lack of funding, Clients
concealing money to resist payments of our fees, loss of clients and excessive
legal fees. “Healthcare” is in Chapter 7 Bankruptcy now case#
6:8-bk-17866.
Revenues
earned for the years ended December 31, 2007 and 2006 were from the operations
of the entities that were discontinued effective June 30, 2007. The Company’s
primary activity of medical billings function was discontinued and has been
presented as discontinued operations in the accompanying financial statements as
of December 31, 2007. The accompanying financial statements have been
reclassified accordingly and presented as discontinued operations. The Company's
other subsidiaries and AutoMed are dormant companies and are also reclassified
as part of discontinued operations as of December 31, 2007. The Company’s
subsidiary “Silver Shadow Properties, LLC was sold to Ms. Basu in 2005. The
Company recorded profit in the transaction.
The
Company computed the beneficial conversion liability of $1,300,000 and warrant
liability of $ 105,762 based on Black-Scholes model. These amounts have been
reflected on the financials as derivative liability in amount of $1,460,962. The
Company recorded a change in fair value of derivative of $277,520 as other
income for the year ended December 31, 2007 compared to a change in fair value
of derivative of $381,684 as other income for the same period in 2006. The
derivative liability originated from the Company’s convertible
notes.
Interest
expense and financing costs for the year ended December 31, 2007 was $247,898
compared to $444,345 for the same period in 2006. The decrease in interest
expense and financing costs are due to decrease of operational cost and
expenses..
The
Company discontinued its operations of medical billings function and recorded a
loss of $2,237,741 for the year ended December 31, 2007 compared to a loss of
$1,175,695 for the same period in 2006. The Company disposed of the assets of
discontinued operations and recorded a loss of $35,957 for the year ended
December 31, 2007.
Net loss
was $2,244,076 (or basic and diluted net loss per share of $(8.74) for the year
ended December 31, 2007 as compared to net loss of $2,997,584 (or basic and
diluted net loss per share of $35.24) for the same period in 2006. Net loss for
the year ended December 31, 2007 was lower as compared to the corresponding
period in the last year since the Company discontinued its primary operations of
medical billings function.
LIQUIDITY
AND CAPITAL RESOURCES (Subsidiary “Healthcare”)
The
“Healthcare” had a working capital deficiency of $6,304,331 as of December 31,
2007. The Company had no assets as of December 31, 2007. The Company had total
current liabilities of $6,304,331 as of December 31, 2007, consisting of
accounts payable and accrued expenses of $1,977,851, accrued officers
compensation of $937,665, line of credit of $100,415, note payable to third
parties of $508,500, lease payable of $18,938, convertible secured note payable
of $1,300,000, and $1,460,962 in derivative liability related to $1,300,000
convertible secured note and warrants associated with the note.
The
“Healthcare” had two revolving lines of credit from two financial institutions
for $50,000 and $100,000. The credit lines are unsecured and bear an annual
interest rate of 10.75% and 16.24%, respectively. The credit lines are
personally guaranteed by the CEO of the Company. The Company has borrowed
$18,065 and $82,350 from the credit lines as of December 31, 2007.
Net cash
used in operating activities of “Healthcare” was $467,242 during the year ended
December 31, 2007, as compared to net cash used in operating activities of
$94,587 during the same period in 2006.
Net cash
used in investing activity during the year ended December 31, 2006 was $45,255
as compared to net cash used in investing activities of $7,290 during the same
period in 2006. Cash used in investing activities during the year ended December
31, 2007 was primarily due to purchase of equipment of $6,277 and software
development costs of $38,978.
Net cash
provided by financing activities was $512,497 during the year ended December 31,
2007, as compared to net cash used by financing activities of $201,246 for the
same period in 2006. Net cash provided during the year ended December 31, 2007
was due to proceeds of $508,500 received from notes payable.
The
Company does not have any commitments or identified sources of additional
capital from third parties or from its officers, directors or majority
shareholders. There is no assurance that additional financing will be available
on favorable terms, if at all. If the Company is unable to raise such additional
financing, it would have a materially adverse effect upon the Company's ability
to implement its business plan and may cause the Company to curtail or scale
back its current operations.
On June
27, 2006, the Company entered into a Securities Purchase Agreement (the
"Securities Purchase Agreement") with New Millennium Capital Partners II, LLC,
AJW Qualified Partners, LLC, AJW Offshore, Ltd. and AJW Partners, LLC
(collectively, the "Investors"). Under the terms of the Securities Purchase
Agreement, the Investors purchased an aggregate of (i) $2,000,000 in callable
convertible secured notes (the "Notes") and (ii) warrants to purchase 125,000
reverse split shares of our common stock (the "Warrants").
Pursuant
to the Securities Purchase Agreement, the Investors purchased the Notes and
Warrants in three trenches as set forth below:
|
At
closing, on July 1, 2006 ("Closing"), the Investors purchased Notes
aggregating $700,000 and warrants to purchase 43,750 shares
based on the prorate shares of our common
stock;
|
|
On
August 8, 2006 the investors purchased Notes aggregating $600,000 and
warrants to purchase 37,500 shares based on the prorate shares of our
common stock.
|
|
Upon
effectiveness of the Registration Statement, the Investors will purchase
Notes aggregating $700,000. The Company never received the third trench as
the Registration Statement was not effective to bring more funds into the
Company.
|
The Notes
carry an interest rate of 6% and a maturity date of June 27, 2009. The notes are
convertible into common shares at the Applicable Percentage of the average of
the lowest three (3) trading prices for our shares of common stock during the
twenty (20) trading day period prior to conversion. The "Applicable Percentage"
means 50%; provided, however, that the Applicable Percentage shall be increased
to (i) 55% in the event that a Registration Statement is filed within thirty
days of the closing and (ii) 60% in the event that the Registration Statement
becomes effective within one hundred and twenty days from the
Closing.
The
Company has an option to prepay the Notes in the event that no event of default
exists, there are a sufficient number of shares available for conversion of the
Notes and the market price is at or below $.05 per share. In addition, in the
event that the average daily price of the common stock, as reported by the
reporting service, for each day of the month ending on any determination date is
below $.05, the Company may prepay a portion of the outstanding principal amount
of the Notes equal to 101% of the principal amount hereof divided by thirty-six
(36) plus one month's interest. Exercise of this option will stay all
conversions for the following month. The full principal amount of the Notes is
due upon default under the terms of Notes. In addition, the Company has granted
the investors a security interest in substantially all of its assets and
intellectual property as well as registration rights.
The
Company simultaneously issued to the Investors seven year warrants to purchase
81,250 shares of common stock at an exercise price of $28.00.
The
Investors have contractually agreed to restrict their ability to convert the
Notes and exercise the Warrants and receive shares of the Company's common stock
such that the number of shares of the Company's common stock held by them and
their affiliates after such conversion or exercise does not exceed 4.99% of the
then issued and outstanding shares of the Company's common stock.
The
Company has received the $ 1,300,000 through December 31, 2007.
RISK
FACTORS
WE NEED A SUBSTANTIAL AMOUNT
OF ADDITIONAL FINANCING.
The
Company anticipates the need for approximately $2,200,000 million dollars of
financing for marketing its products and other operational expenses and
growth. There is no assurance that additional financing will be
available on favorable terms, if at all. If the Company is unable to raise such
additional financing, or accepts financing on unfavorable terms to the Company,
it could have a materially adverse effect upon the Company's ability to
implement its business plan with respect to AutoMed, and other
products.
WE NOW PAY SUBSTANTIALLY
LESS SALARY AND BONUS TO OUR CHIEF EXECUTIVE OFFICER AND
TREASURER.
Our
original employment agreement with Chandana Basu, our Chief Executive Officer
and Treasurer was executed on April 1, 2004 and cannot be terminated by us. It
shall remain in existence until Ms. Basu retires or assigns her position to
others. It provides for a monthly base salary of $5,000 per month and a bonus of
25% of our gross receipts payable monthly with a minimum bonus of $45,000 per
month. It also includes reimbursement of all reasonable expenses. It provides
for the issuance of a minimum of 1,000,000 shares annually as per amendment of
employment agreement in October 2004.
The
Company was never able to pay Ms. Basu such an amount as agreed in her
employment agreement. So Ms Basu amended her employment agreement due to
Company’s financial conditions during the First Quarter of 2008 as
below:
Ms. Basu
will accept $5,000 as salary and $20,000 worth of Company’s Common Shares per
month for the first six months. After six months her salary must increase $1,000
per month to a maximum $10,000 per month and $20,000 worth of Company’s S-8
shares per month until Company’s financial condition changes.
On April
29, 2008 Ms. Basu accepted 100,000,000 shares of the Company Common Shares as a
full payment towards all accrued dues including cost paid by her, bonuses and
note receivable from the Company until this date.
Ms. Basu
also serves as the Chief Executive Officer and President of AutoMed. Ms. Basu is
our only employee at this time. She travels for marketing, deals with the
auditors, attorneys, and investors in addition she works closely with
programmers and other technical professionals to continuously improve the status
of the Company.
WE MAY NOT BE ABLE TO
DEVELOP A MARKET FOR AUTOMED IN THE EVENT THAT WE ARE ABLE TO RAISE ENOUGH MONEY
TO MARKET AUTOMED.
The
Company completed development of the basic version of AutoMed software as a
stand-alone, commercially viable product, the Company plans to market AutoMed as
a "one-stop shopping" solution for medical office management. The Company plans
to charge $50,000 per installation for a single user and one computer. Currently
the Company generates some revenue through AutoMed. The extent to
which AutoMed gains acceptance, if any, will depend, in part, on its cost
effectiveness and performance as compared to conventional means of office
management, as well as known or unknown alternative software packages. If
conventional means of office management or alternative software packages are
more cost-effective or outperform AutoMed, the demand for AutoMed may be
adversely affected. Additionally, the Company anticipates the need for
approximately $2,200,000 Million dollars to begin marketing AutoMed. The failure
of the Company to raise an additional $2,200,000 to implement our Business Plan
and maintain levels of market acceptance would have a material adverse effect on
the line of business and the Company's overall business, financial condition and
results of operations, and would likely cause the value of the Company's
securities to decrease.
OUR AUDITORS HAVE EXPRESSED
AN OPINION THAT THERE IS SUBSTANTIAL DOUBT ABOUT OUR ABILITY TO CONTINUE AS A
GOING CONCERN.
As of
December 31, 2006 the Company has accumulated deficit amounting to $ 6,671,589,
net loss amounting $ 2,997,584, working capital deficit amounting to $ 5,144,299
and net cash used in operations of $ 94,588. The accompanying financial
statements have been prepared assuming that the Company will continue as a going
concern. The financial statements do not include any adjustments that might
result from our inability to continue as a going concern. Our continuation as a
going concern is dependent upon future events, including obtaining financing
(discussed above) for expansion and to implement our business plan with respect
to AutoMed, if we are unable to continue you will loose your
investment.
WE RELY ON KEY
MANAGEMENT.
The
success of the Company depends upon the personal efforts and abilities of
Chandana Basu. The Company faces competition in retaining Ms. Basu and in
attracting new personnel should Ms. Basu choose to leave the Company. There is
no assurance that the Company will be able to retain and/or continue to
adequately motivate Ms. Basu in the future. The loss of Ms. Basu or the
Company's inability to continue to adequately motivate her could have a material
adverse effect on the Company's business and operations.
BECAUSE
MS. CHANDANA BASU OWNS 81.1% OF OUR OUTSTANDING COMMON STOCK, SHE WILL EXERCISE
CONTROL OVER CORPORATE DECISIONS THAT MAY BE ADVERSE TO OTHER MINORITY
SHAREHOLDERS.
Chandana
Basu, a Director of the Company and the Company's Chief Executive Officer and
Treasurer, owns approximately 81.1% of the issued and outstanding shares of our
common stock. Accordingly, she will exercise control in determining the outcome
of all corporate transactions or other matters, including mergers,
consolidations and the sale of all or substantially all of our assets, and also
the power to prevent or cause a change in control. The interests of
Ms. Basu may differ from the interests of the other stockholders and thus
result in corporate decisions that are adverse to other
shareholders.
IF THERE'S A MARKET FOR OUR
COMMON STOCK, OUR STOCK PRICE MAY BE VOLATILE.
If
there's a market for our common stock, we anticipate that such market would be
subject to wide fluctuations in response to several factors, including, but not
limited to:
1.
|
actual
or anticipated variations in our results of
operations;
|
2.
|
our
ability or inability to generate new
revenues;
|
3.
|
increased
competition; and
|
4.
|
conditions
and trends in the medical billing
industry.
|
Further,
because our common stock is trading on the Pink sheets our stock price may be
impacted by factors that are unrelated or disproportionate to our operating
performance. These market fluctuations, as well as general economic, political
and market conditions, such as recessions, interest rates or international
currency fluctuations may adversely affect the market price of our common
stock.
CRITICAL
ACCOUNTING POLICIES
Our
discussion and analysis of our financial condition and results of operations is
based upon our financial statements, which have been prepared in accordance with
accounting principles generally accepted in the United States. The
preparation of these financial statements requires us to make estimates and
judgments that affect the reported amounts of assets, liabilities, revenues and
expenses, and related disclosure of any contingent assets and liabilities. On an
on-going basis, we evaluate our estimates. We base our estimates on various
assumptions that we believe to be reasonable under the circumstances, the
results of which form the basis for making judgments about carrying values of
assets and liabilities that are not readily apparent from other sources. Actual
results may differ from these estimates under different assumptions or
conditions.
ITEM 7.
FINANCIAL STATEMENTS
REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
THE
BOARD OF PPJ ENTERPRISE
We have
audited the accompanying consolidated balance sheet of PPJ Enterprise and
Subsidiaries as of December 31, 2007 and 2006, and the related consolidated
statements of operations, stockholders equity and cash flows for the periods
then ended. These financial statements are the responsibility of the
Company's management. Our responsibility is to express an opinion on these
financial statements based on our audit.
We
conducted our audit in accordance with the standards of the Public Company
Accounting Oversight Board (United States). Those standards require that we plan
and perform our audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. The Company is not required to
have, nor were we engaged to perform, an audit of its internal control over
financial reporting. Our audit included consideration of internal control over
financial reporting as a basis for designing audit procedures that are
appropriate in the circumstances, but not for the purpose of expressing an
opinion on the effectiveness of the Company's internal control over financial
reporting. Accordingly, we express no such opinion. An audit includes examining
on a test basis, evidence supporting the amounts and disclosures in the
financial statements. An audit also includes assessing the accounting principles
used and significant estimates made by management, as well as evaluating the
overall financial statement presentation. We believe that our audit provides a
reasonable basis for our opinion.
In our
opinion, the financial statements referred to above present fairly, in all
material respects, the consolidated financial position of PPJ Enterprise and
Subsidiaries at December 31, 2007 and 2006, and the results of its’ consolidated
operations and its’ consolidated stockholders equity and consolidated cash flows
for the periods then ended in conformity with accounting principles generally
accepted in the United States of America.
The
accompanying consolidated financial statements have been prepared assuming that
the Company will continue as a going concern. The Company's viability is
dependent upon its ability to obtain future financing and the success of its
future operations. These factors raise substantial doubt as to the Company's
ability to continue as a going concern. Management's plan in regard to these
matters is described in Note 2. The financial statements do not include any
adjustments that might result from the outcome of this uncertainty.
Gruber
& Company, LLC Saint Louis, Missouri
November
15, 2008
PPJ Enterprise and
Subsidiaries
Consolidated Balance Sheets
|
|
|
December
31,
|
|
|
|
|
2007
|
|
|
2006
|
|
Assets
|
|
|
|
|
|
|
Property
& Equipment, Net
|
|
$ |
- |
|
|
$ |
41,156 |
|
Software
Development Costs
|
|
|
- |
|
|
|
38,978 |
|
Other
|
|
|
- |
|
|
|
3,650 |
|
|
|
|
|
|
|
|
|
|
|
Total
Assets
|
|
$ |
- |
|
|
$ |
83,784 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities
& Stockholders' (Deficit)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current
Liabilities
|
|
|
|
|
|
|
|
|
|
Accounts
Payable and Accrued Expenses
|
|
$ |
1,977,851 |
|
|
$ |
1,652,796 |
|
|
Accrued
Officer Compensation
|
|
|
937,665 |
|
|
|
337,665 |
|
|
Lines
of Credit
|
|
|
100,415 |
|
|
|
96,418 |
|
|
Derivative
Liability
|
|
|
1,460,962 |
|
|
|
1,738,482 |
|
|
Lease
Liability
|
|
|
18,938 |
|
|
|
18,938 |
|
|
Notes
Payable
|
|
|
508,500 |
|
|
|
- |
|
|
Convertible
Secured Note
|
|
|
1,300,000 |
|
|
|
1,300,000 |
|
|
Total
Current Liabilities
|
|
|
6,304,331 |
|
|
|
5,144,299 |
|
|
|
|
|
|
|
|
|
|
|
Commitments
& Contingencies
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
Stockholders'
Equity (Deficit)
|
|
|
|
|
|
|
|
|
|
Preferred
Stock-Class B, $0.001 par value, 100,000,000 shares
|
|
|
|
|
|
|
|
|
|
authorized;
no shares issued and outstanding.
|
|
|
- |
|
|
|
- |
|
|
Common
Stock, $0.001 par value, 1,500,000,000 shares
|
|
|
|
|
|
|
|
|
|
authorized;
428,226 and 85,200 shares issued and outstanding,
respectively.
|
|
|
428 |
|
|
|
85 |
|
|
Additional
Paid-in Capital
|
|
|
2,535,156 |
|
|
|
1,543,739 |
|
|
Stock
Subscriptions (Receivable) Payable
|
|
|
75,750 |
|
|
|
67,250 |
|
|
Accumulated
Deficit
|
|
|
(8,915,665 |
) |
|
|
(6,671,589 |
) |
|
Total
Stockholders' (Deficit)
|
|
|
(6,304,331 |
) |
|
|
(5,060,515 |
) |
|
|
|
|
|
|
|
|
|
|
Total
Liabilities & Stockholders' (Deficit)
|
|
$ |
- |
|
|
$ |
83,784 |
|
The accompanying notes are an integral part of these financial
statements.
PPJ Enterprise and
Subsidiaries
Consolidated Statements of Operations
|
|
For
the Twelve Months Ended
|
|
|
|
December
31,
|
|
|
|
2007
|
|
|
2006
|
|
Other
Income (Expense)
|
|
|
|
|
|
|
Change
in Fair Value of Derivative
|
|
$ |
277,520 |
|
|
$ |
381,684 |
|
Beneficial
Conversion Feature Expense
|
|
|
- |
|
|
|
(1,756,828 |
) |
Interest
Expense and Financing Costs
|
|
|
(247,898 |
) |
|
|
(444,345 |
) |
Total
Other Income (Expense)
|
|
|
29,622 |
|
|
|
(1,819,489 |
) |
|
|
|
|
|
|
|
|
|
Provision
for Income Taxes
|
|
|
- |
|
|
|
(2,400 |
) |
|
|
|
|
|
|
|
|
|
Net
Income (Loss) Before Discontinued Operations
|
|
|
29,622 |
|
|
|
(1,821,889 |
) |
|
|
|
|
|
|
|
|
|
Loss
from Discontinued Operations
|
|
|
|
|
|
|
|
|
Loss
from Disposal of Assets of Discontinued Operations
|
|
|
(35,957 |
) |
|
|
- |
|
Loss
from Discontinued Operations
|
|
|
(2,237,741 |
) |
|
|
(1,175,695 |
) |
Total
Loss from Discontinued Operations
|
|
|
(2,273,698 |
) |
|
|
(1,175,695 |
) |
|
|
|
|
|
|
|
|
|
Net
Income (Loss)
|
|
$ |
(2,244,076 |
) |
|
$ |
(2,997,584 |
) |
|
|
|
|
|
|
|
|
|
Net
Income per Share
|
|
|
|
|
|
|
|
|
Basic
|
|
$ |
(8.74 |
) |
|
$ |
(35.24 |
) |
Diluted
|
|
$ |
(8.74 |
) |
|
$ |
(35.24 |
) |
|
|
|
|
|
|
|
|
|
Number
of Shares Used in Per Share Calculations
|
|
|
|
|
|
|
|
|
Basic
|
|
|
256,713 |
|
|
|
85,050 |
|
Diluted
|
|
|
256,713 |
|
|
|
85,050 |
|
The accompanying notes are an integral part of these financial
statements.
PPJ Enterprise and
Subsidiaries
Consolidated Statements of Stockholders' Equity (Deficit)
|
|
Common
Stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number
of Shares
|
|
|
Par
Value ($0.001) Amount
|
|
|
Additional
Paid-In-Capital
|
|
|
Prepaid
Consulting
|
|
|
Subscriptions
(Receivable) Payable
|
|
|
Accumulated
Deficit
|
|
|
Total
Stockholders' Equity (Deficit)
|
|
Balance
at December 31, 2005
|
|
84,900 |
|
|
$ |
85 |
|
|
$ |
1,543,727 |
|
|
$ |
(51,611 |
) |
|
$ |
28,500 |
|
|
$ |
(3,674,005 |
) |
|
$ |
(2,153,304 |
) |
Common
Stock Issued to Consultants for Services
|
|
300 |
|
|
|
- |
|
|
|
12 |
|
|
|
51,611 |
|
|
|
- |
|
|
|
- |
|
|
|
51,623 |
|
Common
Shares to be Issued to Directors for Services
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
38,750 |
|
|
|
- |
|
|
|
38,750 |
|
Net
Loss
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(2,997,584 |
) |
|
|
(2,997,584 |
) |
Balance
at December 31, 2006
|
|
85,200 |
|
|
$ |
85 |
|
|
$ |
1,543,739 |
|
|
$ |
- |
|
|
$ |
67,250 |
|
|
$ |
(6,671,589 |
) |
|
$ |
(5,060,515 |
) |
Common
Stock Issued to Consultants for Services
|
|
302,076 |
|
|
|
302 |
|
|
|
876,798 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
877,100 |
|
Common
Shares to be Issued to Directors for Services
|
|
40,950 |
|
|
|
41 |
|
|
|
114,619 |
|
|
|
- |
|
|
|
8,500 |
|
|
|
- |
|
|
|
123,160 |
|
Net
Loss
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(2,244,076 |
) |
|
|
(2,244,076 |
) |
Balance
at December 31, 2007
|
|
428,226 |
|
|
$ |
428 |
|
|
$ |
2,535,156 |
|
|
$ |
- |
|
|
$ |
75,750 |
|
|
$ |
(8,915,665 |
) |
|
$ |
(6,304,331 |
) |
The accompanying notes are an integral part of these financial
statements.
PPJ Enterprise and
Subsidiaries
Consolidated Statements of Cash Flows
|
|
For
the Twelve Months Ended
|
|
|
|
December
31,
|
|
|
|
2007
|
|
|
2006
|
|
Cash
Flows from Operating Activities
|
|
|
|
|
|
|
Net
Income (Loss)
|
|
$ |
(2,244,076 |
) |
|
$ |
(2,997,584 |
) |
|
|
|
|
|
|
|
|
|
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
|
|
|
|
|
|
|
|
Stock
Based Compensation
|
|
|
1,000,260 |
|
|
|
90,373 |
|
Depreciation
& Amortization
|
|
|
93,111 |
|
|
|
118,459 |
|
Beneficial
Conversion Feature Expense
|
|
|
- |
|
|
|
1,756,828 |
|
Change
in Fair Value of Derivative
|
|
|
(277,520 |
) |
|
|
381,684 |
|
Loss
from Disposal of Assets of Discontinued Operations
|
|
|
35,957 |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
Changes
in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
Accounts
Receivable
|
|
|
(29 |
) |
|
|
- |
|
Accounts
Payable and Accrued Expenses
|
|
|
325,055 |
|
|
|
576,378 |
|
Accrued
Officer Compensation
|
|
|
600,000 |
|
|
|
(20,725 |
) |
|
|
|
|
|
|
|
|
|
Net
Cash Used in Operating Activities
|
|
|
(467,242 |
) |
|
|
(94,587 |
) |
|
|
|
|
|
|
|
|
|
Cash
Flows from Investing Activities
|
|
|
|
|
|
|
|
|
Purchase
of Property and Equipment
|
|
|
(6,277 |
) |
|
|
(7,290 |
) |
Software
Development Costs
|
|
|
(38,978 |
) |
|
|
- |
|
|
|
|
|
|
|
|
|
|
Net
Cash Used in Investing Activities
|
|
|
(45,255 |
) |
|
|
(7,290 |
) |
|
|
|
|
|
|
|
|
|
Cash
Flows from Financing Activities
|
|
|
|
|
|
|
|
|
Lines
of Credit
|
|
|
3,997 |
|
|
|
(17,274 |
) |
Payments
on Capital Leases
|
|
|
- |
|
|
|
(6,300 |
) |
Net
Proceeds from Notes Payable
|
|
|
508,500 |
|
|
|
(177,672 |
) |
|
|
|
|
|
|
|
|
|
Net
Cash Provided by Financing Activities
|
|
|
512,497 |
|
|
|
(201,246 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
Increase (Decrease) in Cash
|
|
|
- |
|
|
|
(303,123 |
) |
|
|
|
|
|
|
|
|
|
Cash
Beginning of Period
|
|
|
- |
|
|
|
303,123 |
|
|
|
|
|
|
|
|
|
|
Cash
End of Year
|
|
$ |
- |
|
|
$ |
- |
|
|
|
|
|
|
|
|
|
|
Supplemental
Disclosure of Cash Flow Information:
|
|
|
|
|
|
|
|
|
Cash
Paid during the period for interest
|
|
$ |
- |
|
|
$ |
- |
|
Cash
Paid during the period for income taxes
|
|
|
- |
|
|
|
1,700 |
|
The
accompanying notes are an integral part of these financial statements.
PPJ Enterprise and
Subsidiaries
Notes to Consolidated Financial Statements
Note
1 – Organization, Business & Operations
History
The
Company was incorporated in the State of Nevada on May 2, 2000, as Winfield
Capital Group, Inc. On June 6, 2001, the Company filed a Certificate of
Amendment to its Articles of Incorporation to affect a name change to "Winfield
Financial Group, Inc." On April 23, 2004, the Company acquired 100% of the
equity interest of Healthcare Business Services Groups, Inc. ("Healthcare"). As
part of the same transaction, the Company acquired 100% of the equity interest
of AutoMed Software Corp. ("AutoMed") and Silver Shadow Properties, LLC ("Silver
Shadow") on May 7, 2004. Prior to the Acquisition (defined below), the Company
was a business broker, primarily representing sellers and offering its clients'
businesses for sale. As a result of the acquisition, the Company changed its
business focus to medical billing. On January 7, 2005, the Company filed a
Certificate of Amendment to its Articles of Incorporation, with the Nevada
Secretary of State and changed its name to "Healthcare Business Services Groups,
Inc."
On
April 23, 2004, the Company acquired 100% of the issued and outstanding shares
of Healthcare Business Services Groups, Inc., a Delaware corporation
("Healthcare"). As part of the same transaction on May 7, 2004, the Company
acquired 100% of the issued and outstanding shares of AutoMed Software Corp., a
Nevada corporation ("AutoMed"), and 100% of the membership interests of Silver
Shadow Properties, LLC, a Nevada single member limited liability company
("Silver Shadow"). The transactions are collectively referred to herein as the
"Acquisition." The Company acquired Healthcare, AutoMed, and Silver Shadow from
Chandana Basu, the sole owner, in exchange for 25,150,000 newly issued treasury
shares of the Company's Common Stock. As a result of the Acquisition, the
Company has changed its business focus. The term "Company" shall include a
reference to Healthcare Business Services Groups, Inc. (the
"Company").
The
merger of the Company with Healthcare Business Services Groups Inc., has been
accounted for as a reverse acquisition under the purchase method of accounting
since the shareholders of Healthcare Business Services Groups Inc. obtained
control of the consolidated entity. Accordingly, the merger of the two companies
has been recorded as a recapitalization of the Healthcare Business Services
Groups Inc., with Healthcare Business Services Groups Inc. being
treated as the continuing entity. The continuing company has retained December
31 as its fiscal year end.
Healthcare
was a medical billing service provider that for over fifteen years had assisted
various health care providers to successfully enhance their billing
function.
On July
13, 2007 the Company's Board of Director approved a resolution to discontinue
all of its billing effective June 30, 2007. The accompanying financial
statements have been reclassified accordingly and presented as discontinued
operations. The Company's other three subsidiaries Silver Shadow, AutoMed and
Alta Vista are dormant companies and are also reclassified as part of
discontinued operations.
Name
Change
A
Certificate of Amendment to the Articles of Incorporation to change the
registrant’s name to PPJ Enterprise which amendment became effective on March
20, 2008. As a result of the name change, the Company’s trading symbol changed
from “HBSV” to “PPJE”.
Bankruptcy
Proceedings
On June
26, 2008 Healthcare Business Services Groups, Inc.(“HBSGI”), a Delaware Company,
a subsidiary of PPJ Enterprise (“PPJE”), filed for Chapter 7 Bankruptcy
protection due to lawsuits by its former clients and loss of major clients and
revenue. HBSGI closed its Upland office on June 30, 2007.
Authorized
Shares and Reverse Stock Split
An
amendment to the Registrant’s Articles of Incorporation to increase the
authorized shares to 1,500,000,000 shares of common stock, to reauthorize the
par value of $.001 per share of common stock, and to authorize additional
95,000,000 shares of preferred stock making it a total of 100,000,000 with a par
value of $.001 per share of preferred stock that became effective March 20,
2008; and 300,000,000 Free Trading shares also were registered with Nevada
Secretary of State on March 20, 2008.
On March
20, 2008, the Board of Directors approved an Amendment for a 1:400 reverse stock
split. All references in the financial statements to the number of shares
outstanding, per share amounts, and stock options data of the Company’s common
stock have been restated to reflect the effect of the reverse stock split for
all periods presented.
PPJ Enterprise and
Subsidiaries
Notes to Consolidated Financial Statements
Note
2 - Going Concern and Management's Plans
The
accompanying consolidated financial statements have been prepared in conformity
with generally accepted accounting principles which contemplate
continuation of the company as a going concern. However, as of December 31,
2007, the Company has an stockholders’ deficit of $6,304,331 and an accumulated
deficit of $8,915,665. In addition, the Company has no assets and on June 26,
2008 the Company filed for Chapter 7 Bankruptcy protection for Healthcare
Business Services Groups, Inc .(“HBSGI”), a Delaware Company and subsidiary of
PPJ Enterprise (“PPJE”). These and other factors raise substantial doubt about
the Company's ability to continue as a going concern.
The
ability of the Company to continue as a going concern is dependent upon its
ability to raise additional capital and achieve profitable operations. The
accompanying consolidated financial statements do not include any adjustments
that might be necessary if the Company is unable to continue as a going
concern.
Note
3 - Summary of Significant Accounting Policies
Principles
of Consolidation
The
accompanying consolidated financial statements include the accounts of the
Company and its wholly owned subsidiaries, AutoMed Software Corp., and Silver
Shadow Properties, LLC. All significant inter-company accounts and transactions
have been eliminated in consolidation. The acquisition of Healthcare Business
Services Groups Inc. on May 7, 2004, has been accounted for as a purchase and
treated as a reverse acquisition.
Cash
and Cash Equivalents
The
Company considers all liquid investments with a maturity of three months or less
from the date of purchase that are readily convertible into cash to be cash
equivalents.
Inventories
Inventories
are stated at the lower of cost or market. Cost is computed on a
weighted-average basis, which approximates the first-in, first-out method;
market is based upon estimated replacement costs. Costs included in inventory
primarily include finished spirit product and packaging.
Use
of Estimates
The
preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of
contingent assets and liabilities at the date of the financial statements and
the reported amounts of revenues and expenses during the reporting period.
Actual results could differ from those estimates
Property
& Equipment
Property
and equipment are recorded at cost. Depreciation is computed using the
straight-line method over useful lives of 3 to 10 years. The cost of assets sold
or retired and the related amounts of accumulated depreciation are removed from
the accounts in the year of disposal. Any resulting gain or loss is reflected in
current operations. Assets held under capital leases are recorded at the lesser
of the present value of the future minimum lease payments or the fair value of
the leased property. Expenditures for maintenance and repairs are charged to
operations as incurred.
Impairment
of Long-Lived Assets
Effective
January 1, 2002, the Company adopted Statement of Financial Accounting Standards
No. 144, "Accounting for the Impairment or Disposal of Long-Lived Assets" ("SFAS
144"), which addresses financial accounting and reporting for the impairment or
disposal of long-lived assets and supersedes SFAS No. 121, "Accounting for the
Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed Of,"
and the accounting and reporting provisions of APB Opinion No. 30, "Reporting
the Results of Operations for a Disposal of a Segment of a Business." The
Company periodically evaluates the carrying value of long-lived assets to be
held and used in accordance with SFAS 144. SFAS 144 requires impairment losses
to be recorded on long-lived assets used in operations when indicators of
impairment are present and the undiscounted cash flows estimated to be generated
by those assets are less than the assets' carrying amounts. In that event, a
loss is recognized based on the amount by which the carrying amount exceeds the
fair market value of the long-lived assets. Loss on long-lived assets to be
disposed of is determined in a similar manner, except that fair market values
are reduced for the cost of disposal.
Basic
and Diluted Net Income per Share
Basic
earnings per share is calculated using the weighted-average number of common
shares outstanding during the period without consideration of the dilutive
effect of stock warrants and convertible notes. Diluted earnings per share is
calculated using the weighted-average number of common shares outstanding during
the period after consideration of the dilutive effect of stock warrants and
convertible notes.
PPJ Enterprise and
Subsidiaries
Notes to Consolidated Financial Statements
Stock-Based
Compensation
In
December 2004, the Financial Accounting Standards Board (FASB) issued SFAS No.
123(R), Share-Based Payment. This pronouncement amends SFAS No. 123, Accounting
for Stock-Based Compensation, and supersedes APB Opinion No. 25, Accounting for
Stock Issued to Employees. SFAS No. 123(R) requires that companies account for
awards of equity instruments issued to employees under the fair value method of
accounting and recognize such amounts in their statements of operations. Under
SFAS No. 123(R), we are required to measure compensation cost for all
stock-based awards at fair value on the date of grant and recognize compensation
expense in our consolidated statements of operations over the service period
that the awards are expected to vest.
The
Company accounts for stock-based compensation issued to
non-employees and consultants in accordance with the provisions of SFAS 123(R)
and the Emerging Issues Task Force consensus in Issue No. 96-18 ("EITF 96-18"),
"Accounting for Equity Instruments that are Issued to Other Than Employees for
Acquiring or in Conjunction with Selling, Goods or Services". Common stock
issued to non-employees in exchange for services is accounted for based on the
fair value of the services received.
Fair
Value of Financial Instruments
Statement
of financial accounting standard No. 107, Disclosures about Fair Value of
Financial Instruments, requires that the Company disclose estimated fair values
of financial instruments. The carrying amounts reported in the statements of
financial position for current assets and current liabilities qualifying as
financial instruments are a reasonable estimate of fair value.
Revenue
Recognition
The
Company's revenue recognition policies are in compliance with Staff accounting
bulletin SAB 104. All revenue is recognized when persuasive evidence
of an arrangement exists, the service or sale is complete, the price is fixed or
determinable and collectibility is reasonably assured. Revenue is
derived from collections of medical billing services. Revenue is
recognized when the collection process is complete which occurs when the money
is collected and recognized on a net basis.
License
Revenue - The Company recognizes revenue from license contracts when a
non-cancelable, non-contingent license agreement has been signed, the software
product has been delivered, no uncertainties exist surrounding product
acceptance, fees from the agreement are fixed and determinable and collection is
probable. Any revenues from software arrangements with multiple
elements are allocated to each element of the arrangement based on the relative
fair values using specific objective evidence as defined in the
SOPs. If no such objective evidence exists, revenues from the
arrangements are not recognized until the entire arrangement is completed and
accepted by the customer. Once the amount of the revenue for each
element is determined, the Company recognizes revenues as each element is
completed and accepted by the customer. For arrangements that require
significant production, modification or customization of software, the entire
arrangement is accounted for by the percentage of completion method, in
conformity with Accounting Research Bulletin ("ARB") No. 45 and SOP
81-1.
Services
Revenue - Revenue from consulting services is recognized as the services are
performed for time-and-materials contracts and contract accounting is utilized
for fixed-price contracts. Revenue from training and development
services is recognized as the services are performed. Revenue from
maintenance agreements is recognized ratably over the term of the maintenance
agreement, which in most instances is one year.
Allowance
for Doubtful Accounts
We
provide an allowance for estimated uncollectible accounts receivable balances
based on historical experience and the aging of the related accounts
receivable.
Advertising
The
Company expenses advertising costs as incurred. The Company incurred no
advertising costs for the years ended December 31, 2007 and 2006.
Income
Taxes
The
Company accounts for income taxes using the liability method as required by
Statement of Financial Accounting Standards ("FASB") No. 109, Accounting for
Income Taxes ("SFAS 109"). Under this method, deferred tax assets and
liabilities are determined based on differences between their financial
reporting and tax basis of assets and liabilities. The Company was not required
to provide for a provision for income taxes for the periods ended December 31,
2007 and 2006, as a result of net operating losses incurred during the periods.
As of December 31, 2007, the Company has available approximately $6,900,000 of
net operating losses ("NOL") available for income tax purposes that may be
carried forward to offset future taxable income, if any. These carryforwards
expire in various years through 2026. At December 31, 2007 and 2006, the Company
has deferred tax assets of approximately $3,600,000 and $2,700,000 relating to
the Company's net operating losses, respectively. The Company's deferred tax
asset has been fully reserved by a valuation allowance since realization of its
benefit is uncertain. The Company's ability to utilize its NOL carryforwards may
be subject to an annual limitation in future periods pursuant to Section 382 of
the Internal Revenue Code of 1986, as amended.
PPJ Enterprise and Subsidiaries
Notes to Consolidated Financial Statements
The
provision for income taxes using the federal and state tax rates as compared to
the Company's effective tax rate is summarized as follows:
|
|
December
31,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
|
|
|
|
|
|
|
Statutory
Federal Tax (Benefit) Rate
|
|
|
-34 |
% |
|
|
-34 |
% |
Statutory
State Tax (Benefit) Rate
|
|
|
-6 |
% |
|
|
-6 |
% |
Effective
Tax (Benefit) Rate
|
|
|
-40 |
% |
|
|
-40 |
% |
|
|
|
|
|
|
|
|
|
Valuation
Allowance
|
|
|
40 |
% |
|
|
40 |
% |
|
|
|
|
|
|
|
|
|
Effective
Income Tax
|
|
|
0 |
% |
|
|
0 |
% |
Significant
components of the Company's deferred tax assets at December 31, 2007 and 2006,
are as follows:
|
|
December
31,
|
|
|
|
2007
|
|
|
2006
|
|
Net
Operating Loss Carryforward
|
|
$ |
3,551,109 |
|
|
$ |
2,657,294 |
|
|
|
|
|
|
|
|
|
|
Valuation
Allowance
|
|
|
(3,551,109 |
) |
|
|
(2,657,294 |
) |
|
|
|
|
|
|
|
|
|
Net
Deferred Tax Asset
|
|
$ |
- |
|
|
$ |
- |
|
Research
and Development Costs
Expenditures
for research & development are expensed as incurred. Such costs are required
to be expensed until the point that technological feasibility is established.
The Company incurred no research and development costs for the years ended
December 31, 2007 and 2006.
Reclassifications
Certain
items in the prior year financial statements have been reclassified for
comparative purposes to conform to the presentation in the current period’s
presentation. These reclassifications have no effect on the previously reported
income (loss).
Recently
Issued Accounting Pronouncements
In
December 2007, the FASB issued SFAS No. 141(R), Business Combinations (FAS
141(R)). This Statement provides greater consistency in the accounting and
financial reporting of business combinations. It requires the acquiring entity
in a business combination to recognize all assets acquired and liabilities
assumed in the transaction, establishes the acquisition-date fair value as the
measurement objective for all assets acquired and liabilities assumed, and
requires the acquirer to disclose the nature and financial effect of the
business combination. FAS 141(R) is effective for fiscal years beginning after
December 15, 2008. We will adopt FAS 141(R) no later than the first quarter of
fiscal 2010 and are currently assessing the impact the adoption will have on our
financial position and results of operations.
In
December 2007, the FASB issued SFAS No. 160. Noncontrolling Interests in
Consolidated Financial Statements (FAS 160). This Statement amends Accounting
Research Bulletin No. 51, Consolidated Financial Statements, to establish
accounting and reporting standards for the noncontrolling interest in a
subsidiary and for the deconsolidation of a subsidiary. FAS 160 is effective for
fiscal years beginning after December 15, 2008. We will adopt FAS 160 no later
than the first quarter of fiscal 2010 and are currently assessing the impact the
adoption will have on our financial position and results of
operations.
In
February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial
Assets and Financial Liabilities , which permits entities to choose to measure
at fair value eligible financial instruments and certain other items that are
not currently required to be measured at fair value. This statement requires
that unrealized gains and losses on items for which the fair value option has
been elected be reported in earnings at each subsequent reporting date. SFAS No.
159 is effective for fiscal years beginning after November 15, 2007. We will
adopt SFAS No. 159 no later than the first quarter of fiscal 2009. We are
currently assessing the impact the adoption of SFAS No. 159 will have on our
financial position and results of operations.
In
September 2006, the FASB issued SFAS No. 158, Employers’ Accounting for Defined
Benefit Pension and Other Postretirement Plans, an amendment of FASB Statements
No. 87, 88, 106, and 132(R) . SFAS No. 158 requires company plan sponsors to
display the net over or under-funded position of a defined benefit
postretirement plan as an asset or liability, with any unrecognized prior
service costs, transition obligations or actuarial gains/losses reported as a
component of other comprehensive income in shareholders’ equity. SFAS No. 158 is
effective for fiscal years ending after December 15, 2006. We adopted the
recognition provisions of SFAS No. 158 as of the end of fiscal 2007. The
adoption of SFAS No. 158 did not have an effect on the Company’s financial
position or results of operations.
PPJ Enterprise and
Subsidiaries
Notes to Consolidated Financial Statements
In
September 2006, the FASB issued SFAS No. 157, Fair Value Measurements. SFAS No.
157 establishes a framework for measuring fair value in generally accepted
accounting principles, clarifies the definition of fair value and expands
disclosures about fair value measurements. SFAS No. 157 does not require any new
fair value measurements. However, the application of SFAS No. 157 may change
current practice for some entities. SFAS No. 157 is effective for financial
statements issued for fiscal years beginning after November 15, 2007, and
interim periods within those fiscal years. We will adopt SFAS No. 157 in the
first quarter of fiscal 2009. We are currently assessing the impact that the
adoption of SFAS No. 157 will have on our financial position and results of
operations.
In July
2006, the FASB issued Interpretation No. 48, Accounting for Uncertainty in
Income Taxes — an interpretation of FASB Statement No. 109 (FIN 48). This
interpretation clarifies the application of SFAS No. 109, Accounting for Income
Taxes , by defining a criterion that an individual tax position must meet for
any part of the benefit of that position to be recognized in an enterprise’s
financial statements and also provides guidance on measurement, derecognition,
classification, interest and penalties, accounting in interim periods,
disclosure and transition. FIN 48 is effective for fiscal years beginning after
December 15, 2006, but earlier adoption is permitted. The Company is in the
process of evaluating the impact of the application of the Interpretation to its
financial statements.
Note
4 – Discontinued Operations
On July
13, 2007 the Company's Board of Director approved a resolution to discontinue
all of its billing function (the principal activity of the Company) effective
June 30, 2007. The accompanying financial statements have been reclassified
accordingly and presented as discontinued operations. The Company's other three
subsidiaries; Silver Shadow, AutoMed and Alta Vista, are dormant companies and
are also reclassified as part of discontinued operations.
|
|
For
the Twelve Months Ended
|
|
|
|
December
31,
|
|
|
|
|
|
|
|
|
Net
Revenue
|
|
$ |
678,277 |
|
|
$ |
1,011,644 |
|
Operating
Expenses
|
|
|
2,916,018 |
|
|
|
2,187,339 |
|
Loss
from Discontinued Operations
|
|
|
(2,237,741 |
) |
|
|
(1,175,695 |
) |
Note
5 - Property and Equipment
As of
December 31, 2007 and 2006, property and equipment is comprised of the
following:
|
|
December
31,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
|
|
|
|
|
Office
and Computer Equipment
|
|
|
- |
|
|
|
124,964 |
|
Furniture
& Equipment
|
|
|
- |
|
|
|
89,869 |
|
|
|
|
|
|
|
|
|
|
Less:
Accumulated Depreciation
|
|
|
- |
|
|
|
(173,677 |
) |
|
|
|
|
|
|
|
|
|
Net
Property & Equipment
|
|
$ |
- |
|
|
$ |
41,156 |
|
|
|
|
|
|
|
|
|
|
Depreciation
Expense
|
|
$ |
93,111 |
|
|
$ |
30,133 |
|
|
|
|
- |
|
|
|
41,156 |
|
During
the years ended December 31, 2007 and 2006, the Company recorded depreciation
expense of $15,155 and $30,133, respectively.
Note
6 – Software Development Costs
The
Company is accounting for computer software technology costs under the
Capitalization criteria of Statement of Position 98-1 "Accounting for the Costs
of Computer Software Developed or Obtained for Internal Use."
Expenditures
for maintenance and repairs are expensed when incurred; additions, renewals and
betterments are capitalized. Amortization is computed using the
straight-line method over the estimated useful life of the
asset. Amortization begins from the date when the software becomes
operational. The website became operational July 1,
2004. The Company amortized $38,978 and $ 88,326 in the accompanying
financial statements at December 31, 2007 and 2006, respectively. The balance at
December 31, 2007 amounts was $0.
PPJ Enterprise and
Subsidiaries
Notes to Consolidated Financial Statements
Note
7– Accounts Payable and Accrued Expenses
As of
December 31, 2007 and 2006, accounts payable and accrued expenses consist of the
following:
|
|
December
31,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
|
|
|
|
|
Trade
Payable
|
|
$ |
404,395 |
|
|
$ |
597,687 |
|
Payable
to Clients
|
|
|
1,127,004 |
|
|
|
591,609 |
|
Litigation
Accrual
|
|
|
50,000 |
|
|
|
325,000 |
|
Accrued
Interest
|
|
|
264,634 |
|
|
|
35,819 |
|
Income
Tax Payable
|
|
|
60,000 |
|
|
|
8,655 |
|
Accrued
Payroll & Taxes
|
|
|
12,777 |
|
|
|
12,627 |
|
Accrued
Vacation
|
|
|
13,114 |
|
|
|
13,111 |
|
Other
Accrued Expenses
|
|
|
45,927 |
|
|
|
68,288 |
|
Total
Accounts Payable and Accrued Expenses
|
|
$ |
1,977,851 |
|
|
$ |
1,652,796 |
|
Note
8 – Accrued Officer Compensation
The
Company has an employment agreement with Chandana Basu, our Chief Executive
Officer and Treasurer. The Agreement was executed on April 1, 2004 and can not
be terminated. It shall remain in existence until Ms. Basu retires or assigns
her position to others. It provides for a monthly base salary of $5,000 per
month and a bonus of 25% of our gross receipts payable monthly with a minimum
bonus of $45,000 per month. It also includes reimbursement of all reasonable
expenses. It provides for the issuance of a minimum of 1,000,000 shares annually
as per amendment of employment agreement in October 2005.
As of
December 31, 2007 and 2006, accrued officer compensation totaled $937,665 and
$337,665, respectively.
Note
9 – Lines of Credit
The
Company has two revolving lines of credit from two financial institutions for
$50,000 and $100,000. The credit lines are unsecured and bear an
annual interest rate of 10.75% and 16.24%, respectively. The credit
lines are personally guaranteed by the CEO of the Company. The
Company has borrowed $18,065 and $82,350 from the credit lines as of December
31, 2007.
Note
10 – Notes Payable
The
Company has 7 unsecured promissory notes with 5 individuals totaling
$508,500. These notes accrue interest between 8% and 25% annualized
and are all due on or before December 31, 2008. As of the audit date,
the Company is in default on 5 of these notes totaling $468,500.
Note
11 - Convertible Secured Note and Securities Purchase Agreement
On June
27, 2006, the Company entered into a Securities Purchase Agreement (the
"Securities Purchase Agreement") with New Millennium Capital Partners II, LLC,
AJW Qualified Partners, LLC, AJW Offshore, Ltd. and AJW Partners, LLC
(collectively, the "Investors"). Under the terms of the Securities Purchase
Agreement, the Investors purchased an aggregate of (i) $2,000,000 in callable
convertible secured notes (the "Notes") and (ii) warrants to purchase 125,000
reverse split shares of our common stock (the "Warrants").
Pursuant
to the Securities Purchase Agreement, the Investors purchased the Notes and
Warrants in three trenches as set forth below:
·
|
At
closing, on July 1, 2006 ("Closing"), the Investors purchased Notes
aggregating $700,000 and warrants to purchase 43,750 shares
based on the prorate shares of our common
stock;
|
·
|
On
August 8, 2006 the investors purchased Notes aggregating $600,000 and
warrants to purchase 37,500 shares based on the prorate shares of our
common stock.
|
·
|
Upon
effectiveness of the Registration Statement, the Investors will purchase
Notes aggregating $700,000. The Company has withdrawn the third trench as
the Registration Statement was not effective to bring more funds into the
Company.
|
The Notes
carry an interest rate of 6% and a maturity date of June 27, 2009. The notes are
convertible into common shares at the Applicable Percentage of the average of
the lowest three (3) trading prices for our shares of common stock during the
twenty (20) trading day period prior to conversion. The "Applicable Percentage"
means 50%; provided, however, that the Applicable Percentage shall be increased
to (i) 55% in the event that a Registration Statement is filed within thirty
days of the closing and (ii) 60% in the event that the Registration Statement
becomes effective within one hundred and twenty days from the
Closing.
The
Company has an option to prepay the Notes in the event that no event of default
exists, there are a sufficient number of shares available for conversion of the
Notes and the market price is at or below $.05 per share. In addition, in the
event that the average daily price of the common stock, as reported by the
reporting service, for each day of the month ending on any determination date is
below $.05, the Company may prepay a portion of the outstanding principal amount
of the Notes equal to 101% of the principal amount hereof divided by thirty-six
(36) plus one month's interest. Exercise of this option will stay all
conversions for the following month. The full principal amount of the Notes is
due upon default under the terms of Notes. In addition, the Company has granted
the investors a security interest in substantially all of its assets and
intellectual property as well as registration rights.
The
Company has received the $ 1,300,000 through December 31, 2007.
PPJ Enterprise and
Subsidiaries
Notes to Consolidated Financial Statements
Note
12 – Derivative Liability
Concurrent
with the issuance of the $1,300,000 note detailed in Note 11, the Company issued
to the Investors seven year warrants to purchase 81,250, post reverse split
shares, of common stock at an exercise price of $28.00.
The
Investors have contractually agreed to restrict their ability to convert the
Notes and exercise the Warrants and receive shares of the Company's common stock
such that the number of shares of the Company's common stock held by
them and
their affiliates after such conversion or exercise does not exceed 4.99% of the
then issued and outstanding shares of the Company's common stock.
The fair
value of the share purchase warrants for the period December 31, 2007, was in
the amount of $1,460,962, which was determined using the Black-Scholes option
value model with the following assumptions:
·
|
Expected
life 5.6 years
|
Note
13 - Stockholders’ Equity
Authorized
Shares
An
amendment to the Registrant’s Articles of Incorporation to increase the
authorized shares to 1,500,000,000 shares of common stock, to reauthorize the
par value of $.001 per share of common stock, and to authorize additional
95,000,000 shares of preferred stock making it a total of 100,000,000 with a par
value of $.001 per share of preferred stock that became effective March 20,
2008; and 300,000,000 Free Trading shares also were registered with Nevada
Secretary of State on March 20, 2008.
Reverse
Stock Split
On March
20, 2008, the Board of Directors approved an Amendment for a 1:400 reverse stock
split. . All references in the financial statements to the number of shares
outstanding, per share amounts, and stock options data of the Company’s common
stock have been restated to reflect the effect of the reverse stock split for
all periods presented.
Common
Stock
As of
December 31, 2007, 428,226 common shares were issued and
outstanding. The holders of common stock, and of shares issuable upon
exercise of any Warrants or Options, are entitled to equal dividends and
distributions, per share, with respect to the common stock when, as and if
declared by the Board of Directors from funds legally available
therefore. No holder of any shares of common stock has a pre-emptive
right to subscribe for any securities of the Company nor is any common shares
subject to redemption or convertible into other securities of the
Company. Upon liquidation, dissolution or winding up of the Company,
and after payment of creditors and preferred stockholders, if any, the assets
will be divided pro-rata on a share-for-share basis among the holders of the
shares of common stock. All shares of common stock now outstanding
are fully paid, validly issued and non-assessable. Each share of
common stock is entitled to one vote with respect to the election of any
director or any other matter upon which shareholders are required or permitted
to vote. Holders of the Company's common stock do not have cumulative
voting rights, so that the holders of more than 50% of the combined shares
voting for the election of directors may elect all of the directors, if they
choose to do so and, in that event, the holders of the remaining shares will not
be able to elect any members to the Board of Directors.
During
the year ended December 31, 2007, the Company issued 343,026 restricted common
shares of which 302,076 shares were issued to Consultants for services totaling
$877,100 and 40,950 shares were issue to Directors for services totaling
$114,660. As of December 31, 2008, subscriptions payable totals
$75,750.
During
the year ended December 31, 2006, the Company issued 300 restricted common
shares to Consultants for services totaling $51,623.
PPJ Enterprise and Subsidiaries
Notes to Consolidated Financial Statements
Class
B Preferred Stock
The
Company's Articles of Incorporation (Articles") authorize the issuance of
100,000,000 shares of $0.001 par value Class B Preferred Stock. No
shares of Preferred Stock are currently issued and outstanding. Under
the Company's Articles, the Board of Directors has the power, without further
action by the holders of the Common Stock, to designate the relative rights and
preferences of the preferred stock, and issue the preferred stock in such one or
more series as designated by the Board of Directors. The designation
of rights and preferences could include preferences as to liquidation,
redemption and conversion rights, voting rights, dividends or other preferences,
any of which may be dilutive of the interest of the holders of the Common Stock
or the Preferred Stock of any other series. The issuance of Preferred
Stock may have the effect of delaying or preventing a change in control of the
Company without further shareholder action and may adversely affect the rights
and powers, including voting rights, of the holders of Common
Stock. In certain circumstances, the issuance of preferred stock
could depress the market price of the Common Stock.
Note
14 – Related Party Transactions
The
Company recorded $5,250 as officer compensation for 750,000 shares to be issued
pursuant to the employment agreement. The
officer is entitled to 1,000,000 shares every year pursuant to the employment
agreement.
During
the year ended December 31, 2007, the Company issued 40,950 post reverse split
restricted common shares to the following in consideration for services
performed.
|
|
Number
of Shares
|
|
|
|
|
|
Directors
(2)
|
|
|
375 |
|
*Director
and Husband
|
|
|
7,500 |
|
CEO
and Director
|
|
|
7,500 |
|
*Ex-Employee-Son
|
|
|
2,500 |
|
*Ex-Employee-Daughters
(2)
|
|
|
7,500 |
|
*Ex-Employee-Son
in Law
|
|
|
500 |
|
Ex
Employees (8)
|
|
|
2,387 |
|
Contractors
(6)
|
|
|
12,689 |
|
Total
|
|
|
40,950 |
|
* The above are in relationship to the CEO and
Director of the Company.
The
Company recorded the 40,950 shares at the fair market value of $114,660 as
compensation expense.
Note
15– Commitments & Contingencies
Leases
During
the year ended December 31, 2007, the Company leased its corporate offices space
in Upland, California under operating lease agreement. The facility
lease calls for a monthly rent of $3,387.
The
Company is on a month to month lease and vacated the leased premises as of
September 30, 2007. Currently, the Company is operating thru a marketing company
in Nevada for collection only and there are no on going billing
operations.
PPJ Enterprise and
Subsidiaries
Notes to Consolidated Financial Statements
Litigation
The
Company is currently plaintiff to two and defendant to two law suits. The
Company filed claims for non payment of fees by former clients due to clients
diverted funds billed by company and did not pay Billing fees.
·
|
On
July 12, 2004, Nimish Shah, M.D. d/b/a New Horizon Medical, Inc. ("New
Horizon") initiated a lawsuit against the Company in the Superior Court of
California, County of Los Angeles, Case No. VC 042695, styled New Horizon
Medical, Inc. v. HBSGI, et al. In connection with arbitration, the Company
has claimed against New Horizon the compensatory damages in the amount of
$75,000 (subject to amendment), prejudgment interest, costs and attorneys'
fees in an unspecified amount. New Horizon has not submitted a
cross-complaint against the Company for the breach of contract alleging
that there is substantial discrepancy between the amounts of bills
provided by New Horizon to the Company, for the purpose of securing
payment from various insurance companies, and the funds actually received
from the Company. This matter was dismissed by arbitrator for non payment
of arbitrator's fee.
|
·
|
In
January 2004, Claimant Leonard J. Soloniuk, MD initiated an arbitration
against HBSGI with the American Arbitration Association, Case No. 72 193
00102 04 TMS, styled Leonard J. Soloniuk, MD v. HBSGI. In a decision dated
April 5, 2006, the arbitrator awarded HBSGI nothing against Soloniuk. The
arbitrator further awarded Soloniuk $ 275,000 against the HBSGI as well as
interest accruing from June 1, 2006, at the rate of ten percent per annum
on the unpaid balance. The arbitrator further ordered HBSGI to reimburse
Soloniuk costs in the amount of $ 1,875. Company argues that of this
$275,000, $210,000 was already paid to Soloniuk since November 4, 2002,
last date of payment were considered by arbitrator and therefore the
judgment should be reduced accordingly. The Company can provide no
assurances that it will be successful in this
argument.
|
·
|
Company
recently filed new legal actions against Soloniuk for fraud, deception,
and intentional non disclosure of money received from HBSGI collection to
the arbitration hearing to gain advantage. Company also filed an
application of injunction to prevent Soloniuk to use HBSGI billing method.
Hearing is set for May 10, 2007. Company is suing Solonuik for $750,000
plus cost of lawsuit.
|
·
|
On
November 1, 2007 “Healthcare” filed law suit against Narinder Grewal, MD
for unpaid fees and damages of $3,000,000 (case No. CIVRS706024.) Dr.
Grewal filed a counter suit.
|
·
|
On
September 20, 1999, Mohammad Tariq, MD was granted a default judgment in
the District Court of Collin County, Texas, 380th Judicial District in the
amount of $280,835.10, plus prejudgment and post-judgment interest against
Healthcare Business Services Group, Inc., d/b/a/ Peacock
Healthcare. Kamran Ghadimi bought the Tariq judgment in April
28, 2006 and pursuing collection in California. This matter was
settled on November 8, 2006 for $185,000. The Company paid $140,000 out of
$185,000 and making payments monthly for $3,000. As of filing this report
company owes 15 months of payment equal to $45,000. Case was dismissed in
2007.
|
·
|
Healthcare
filed a collection action against Frank Zondlo, and Zondlo also filed
across-complaint against Healthcare. The matter is now in the
discovery and law and motion stage.
|
Bankruptcy
Proceedings
On June
26, 2008 Healthcare Business Services Groups, Inc.(“HBSGI”), a Delaware Company,
a subsidiary of PPJ Enterprise (“PPJE”), filed for Chapter 7 Bankruptcy
protection. HBSGI has been over burdened with law suits by its former clients
and loss of major clients and revenue. HBSGI closed its Upland office on June
30, 2007.
From time
to time, we may become party to litigation or other legal proceedings that we
consider to be a part of the ordinary course of our business. Other than the
legal proceedings listed below, we are not currently involved in legal
proceedings that could reasonably be expected to have a material adverse effect
on our business, prospects, financial condition or results of operations.
However, we may become involved in material legal proceedings in the
future.
Note
16 - Subsequent Events
Name
Change
A
Certificate of Amendment to the Articles of Incorporation to change the
registrant’s name to PPJ Enterprise which amendment became effective on March
20, 2008. As a result of the name change, the Company’s trading symbol changed
from “HBSV” to “PPJE”.
Bankruptcy
Proceedings
On June
26, 2008 Healthcare Business Services Groups, Inc.(“HBSGI”), a Delaware Company,
a subsidiary of PPJ Enterprise (“PPJE”), filed for Chapter 7 Bankruptcy
protection. HBSGI has been over burdened with law suits by its former clients
and loss of major clients and revenue. HBSGI closed its Upland office on June
30, 2007.
Authorized
Shares and Reverse Stock Split
An
amendment to the Registrant’s Articles of Incorporation to increase the
authorized shares to 1,500,000,000 shares of common stock, to reauthorize the
par value of $.001 per share of common stock, and to authorize additional
95,000,000 shares of preferred stock making it a total of 100,000,000 with a par
value of $.001 per share of preferred stock that became effective March 20,
2008; and 300,000,000 Free Trading shares also were registered with Nevada
Secretary of State on March 20, 2008.
On March
20, 2008, the Board of Directors approved an Amendment for a 1:400 reverse stock
split. . All references in the financial statements to the number of shares
outstanding, per share amounts, and stock options data of the Company’s common
stock have been restated to reflect the effect of the reverse stock split for
all periods presented.
Equity
Subsequent
to the year ended December 31, 2007, the Company issued 133,800,000 shares of
common stock of which 100,000,000 was issued to an Officer for debt conversion,
29,800,000 shares were issued to non-affiliated individuals for services and
4,000,000 shares were issued for the conversion of debt.
ITEM
8. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS
We have
had no disagreements with our independent accountants.
ITEM
8A. CONTROLS AND PROCEDURES
The
Company maintains a set of disclosure controls and procedures designed to ensure
that information required to be disclosed by the Company in the reports filed
under the Securities Exchange Act, is recorded, processed, summarized and
reported within the time periods specified by the SEC's rules and forms.
Disclosure controls are also designed with the objective of ensuring that this
information is accumulated and communicated to the Company's management,
including the Company's chief executive officer and chief financial officer, as
appropriate, to allow timely decisions regarding required
disclosure.
Our
management does not expect that our disclosure controls or internal controls
over financial reporting will prevent all errors or all instances of fraud. A
control system, no matter how well designed and operated, can provide only
reasonable, not absolute, assurance that the control system's objectives will be
met. Further, the design of a control system must reflect the fact that there
are resource constraints, and the benefits of controls must be considered
relative to their costs. Because of the inherent limitations in all control
systems, no evaluation of controls can provide absolute assurance that all
control issues and instances of fraud, if any, within our company have been
detected. These inherent limitations include the realities that judgments in
decision-making can be faulty, and that breakdowns can occur because of simple
error or mistake. Because of the inherent limitation of a cost-effective control
system, misstatements due to error or fraud may occur and not be
detected.
Based
upon their evaluation as of the end of the period covered by this report, the
Company's chief executive officer and chief financial officer concluded that,
the Company's disclosure controls and procedures are not effective to ensure
that information required to be included in the Company's periodic SEC filings
is recorded, processed, summarized, and reported within the time periods
specified in the SEC rules and forms.
This
deficiency consisted primarily of inadequate staffing and supervision that could
lead to the untimely identification and resolution of accounting and disclosure
matters and failure to perform timely and effective reviews. However, the size
of the Company prevents us from being able to employ sufficient resources to
enable us to have adequate segregation of duties within our internal control
system. Management is required to apply its judgment in evaluating the
cost-benefit relationship of possible controls and procedures.
ITEM
8B. OTHER INFORMATION
PART
III
ITEM
9. DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL
PERSONS; COMPLIANCE WITH SECTION 16(A) OF THE EXCHANGE ACT
Directors
are elected by the stockholders to a term of one year and serves until his or
her successor is elected and qualified. Officers are appointed by the Board of
Directors to a term of one year and serves until his or her successor is duly
elected and qualified, or until he or she is removed from office. Our Board of
Directors has no nominating, auditing or compensation committees.
The
following table sets forth certain information regarding our executive officers
and directors as of the date of this report:
|
|
Age
|
|
Position
|
Chandana
Basu
|
|
53
|
|
Chief
Executive Officer, Treasurer and Director
|
Abhijit
Bhattacharya
|
|
60
|
|
Director
|
Arjinderpal
Singh Sekhon, MD
|
|
59
|
|
Director
|
The above
listed officers and directors will serve until the next annual meeting of the
shareholders or until their death, resignation, retirement, removal, or
disqualification, or until their successors have been duly elected and
qualified. Vacancies in the existing Board of Directors are filled by majority
vote of the remaining Directors. Officers of the Company serve at the will of
the Board of Directors .To the Company's knowledge, there are no agreements or
understandings for any officer or director to resign at the request of another
person nor is any officer or director acting on behalf of or is to act at the
direction of any other person other than in his fiduciary capacity of and for
the benefit of the Company and at its direction.
Set forth
below is certain biographical information regarding our executive officers and
directors:
Chandana
Basu - Chief Executive Officer, Treasurer and Director
Chandana
Basu has served as our Chief Executive Officer and Treasurer since May 2004,
after we acquired Healthcare Business Services Group, Inc. ("“Healthcare”"), a
full-service medical billing agency and our wholly-owned subsidiary. She has
served as our director since November 12, 2004. Ms. Basu incorporated
“Healthcare” in December 1994. Ms. Basu has operated “Healthcare” for the
past 18 years as of 2001. Ms. Basu has been grown “Healthcare” from a core
client base of doctors and hospitals in California, Florida, Washington State
and Texas without the use of consistent marketing or advert advertising. Ms.
Basu has over 19 years of experience in medical bill collecting from insurance
companies.
Family
Relationships
None.
Board
Committees
We
currently have no compensation committee or other board committee performing
equivalent functions. Currently, all members of our board of directors
participate in discussions concerning executive officer
compensation.
Involvement
on Certain Material Legal Proceedings During the Last Five Years
No
director, officer, significant employee or consultant has been convicted in a
criminal proceeding, exclusive of traffic violations.
No
bankruptcy petitions have been filed by or against any business or property of
any director, officer, significant employee or consultant of the Company nor has
any bankruptcy petition been filed against a partnership or business association
where these persons were general partners or executive officers.
No
director, officer, significant employee or consultant has been permanently or
temporarily enjoined, barred, suspended or otherwise limited from involvement in
any type of business, securities or banking activities.
No
director, officer or significant employee has been convicted of violating a
federal or state securities or commodities law.
Section
16(a) Beneficial Ownership Reporting Compliance
Section
16(a) of the Securities Exchange Act of 1934, as amended, requires the Company's
directors and executive officers, and persons who beneficially own more than 10%
of a registered class of the Company's equity securities, to file reports of
beneficial ownership and changes in beneficial ownership of the Company's
securities with the SEC on Forms 3 (Initial Statement of Beneficial Ownership),
4 (Statement of Changes of Beneficial Ownership of Securities) and 5 (Annual
Statement of Beneficial Ownership of Securities). Directors, executive officers
and beneficial owners of more than 10% of the Company's Common Stock are
required by SEC regulations to furnish the Company with copies of all Section
16(a) forms that they file. Except as otherwise set forth herein, based solely
on review of the copies of such forms furnished to the Company, or written
representations that no reports were required, the Company believes that for the
fiscal year ended December 31, 2005 beneficial owners did not comply with
Section 16(a) filing requirements applicable to them to the extent they filed
all form required under Section 16(a) in February 2005 and had no trading
activity in 2005.
Code
of Ethics
We have
not adopted a Code of Business Conduct and Ethics that applies to our principal
executive officer, principal financial officer, principal accounting officer or
controller, or persons performing similar functions in that our sole officer and
director serves in all the above capacities.
|
|
|
|
|
|
Name
and Principal Position
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted
Stock Compensation
|
|
Securities
Underlying Options
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
35,000 |
|
(1 |
) |
|
$ |
540,000 |
** |
|
(1 |
)* |
|
600,000 |
|
(3 |
) |
|
0 |
|
0 |
|
Chief
Executive Officer, Treasurer
and Director
|
|
|
|
|
$ |
60,000 |
|
(2 |
) |
|
$ |
540,000 |
*** |
|
(2 |
) |
|
** |
|
|
|
|
0 |
|
0 |
|
(1)
|
Chandana
Basu is to receive a salary of $5,000 per month and a minimum bonus of
$45,000 per month pursuant to an employment agreement with Healthcare as
until 12/31/2007.
|
*Paid
in Common Shares of the Company.
**All
of these paid by Common shares of the Company
***most
of this amount paid in Common Shares of the Company
Ms Basu did not sell any of her
shares as of November 19, 2008.
OPTIONS
GRANTS IN PRESENT FISCAL YEAR (Individual Grants)
|
Number of securities
underlying
options granted (#)
|
Percent of total options granted
to
employees in last fiscal
year
|
Exercise or Base
Price ($/Share)
|
Expiration
Date
|
None
|
|
|
|
|
AGGREGATED
OPTION EXERCISES IN LAST FISCAL YEAR AND FISCAL YEAR-END OPTION
VALUES
Aggregated
Option Exercises and Fiscal Year-End Option Value Table. The following table
sets forth certain information regarding stock options exercised during fiscal
year ending December 31, 2005, by the executive officer named in the Summary
Compensation Table.
|
Shares
acquired
on
exercise (#)
|
Value
realized
($)
|
Number
of Securities Underlying Unexercised Options
at
Fiscal Year-End (#)
|
Value
of Unexercised In-the-Money Options
at
Fiscal Year- End ($) (1)
|
|
|
|
Exercisable/
Unexercisable
|
Exercisable/
Unexercisable
|
NONE
Employment
Contracts
We have
an employment agreement with Chandana Basu, our Chief Executive Officer and
Treasurer. The Agreement was executed on April 1, 2004 and can not be terminated
by us. It shall remain in existence until Ms. Basu retires or assigns her
position to others. It provides for a monthly base salary of $5,000 per month
and a bonus of 25% of our gross receipts payable monthly with a minimum bonus of
$45,000 per month. It also includes reimbursement of all reasonable expenses. It
provides for the issuance of a minimum of 1,000,000 shares annually as per
amendment of employment agreement in October 2004.
The
Company was never able to pay Ms. Basu such an amount as agreed in her
employment agreement. So Ms Basu amended her employment agreement due to
Company’s financial conditions during the Fourth Quarter of 2007 as
below:
This
agreement was modified on January 6, 2008 as below:
Ms. Basu
will accept $5,000 as salary and $20,000 worth of Company’s Common Shares per
month for the first six months. After six months her salary must increase $1,000
per month to a maximum $10,000 per month and $20,000 worth of Company’s S-8
shares per month until financial conditions are changed.
Modifications
will be reviewed as the Company’s financial conditions changes.
On April
29, 2008 Ms. Basu accepted 100,000,000 shares of the Company Common Shares as a
full payment towards all accrued dues including cost paid by her, bonuses and
note receivable from the Company until this date.
Ms. Basu
also serves as the Chief Executive Officer and President of AutoMed. Ms. Basu is
our only employee at this time. She travels for marketing, deals with the
auditors, attorneys and investors in addition works directly with programmers
and other technical people to continuously improve the status of the
Company.
Based on
our 2006 financing, we were required to purchase $4,000,000 of additional key
man life insurance on the life of Chandana Basu, our Chief Executive Officer and
Treasurer. $20,000 has been paid to fund the above additional insurance
policy.
Compensation
of Directors
Directors
are permitted to receive fixed fees and other compensation for their services as
directors. The Board of Directors has the authority to fix the compensation of
directors. No amounts have been paid to, or accrued for, directors in such
capacity.
|
SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
MANAGEMENT
|
Security
Ownership of Certain Beneficial Owners and Management
The
following table sets forth certain information derived from the named person, or
from the transfer agent, concerning the ownership of common stock as of July 26,
2006, of (i) each person who is known to us to be the beneficial owner of more
than 5 percent of the common stock; (ii) all directors and executive officers;
and (iii) directors and executive officers as a group:
Name
and Address of Beneficial Owner
|
|
Amount
and Nature of Beneficial Ownership
|
|
Percent
of Class (1)
|
|
|
|
|
|
|
|
Chandana
Basu
|
|
100,625,000 |
|
75.8 |
% |
1105
Terminal Way, Suite 202
Reno,
NV 89502
|
|
|
|
|
|
|
|
|
|
|
|
Abhijit
Bhattacharya
|
|
1.125,000 |
|
0.003 |
% |
1105
Terminal Way, Suite 202
Reno,
NV 89502
|
|
|
|
|
|
|
|
|
|
|
|
Arjinderpal
Singh Sekhon, MD
|
|
|
|
|
|
1105
Terminal Way
|
|
1,025,000 |
|
0.002 |
% |
Reno,
NV 89502
|
|
|
|
|
|
|
|
|
|
|
|
Officers
and Directors as a Group (3 persons)
|
|
102,775,000 |
|
76.804 |
% |
(1) Based
on 128,766,000 shares issued and outstanding as of September 19,
2008.
Under the
terms of the callable secured convertible note and the related warrants, the
callable secured convertible note and the warrants are exercisable by any holder
only to the extent that the number of shares of common stock issuable pursuant
to such securities, together with the number of shares of common stock owned by
such holder and its affiliates (but not including shares of common stock
underlying unconverted shares of callable secured convertible notes or
unexercised portions of the warrants) would not exceed 4.99% of the then
outstanding common stock as determined in accordance with Section 13(d) of the
Exchange Act. Therefore, the table does not include AJW Partners, LLC, AJW
Offshore, Ltd., AJW Qualified Partners, LLC and New Millenium Capital Partners
II, LLC.
Change
in Control
No
arrangements exist that may result in a change of control of Healthcare Business
Services Group, Inc.
|
CERTAIN
RELATIONSHIPS AND RELATED
TRANSACTIONS
|
On
January 13, 2005, our majority shareholder and Chief Executive Officer, Chandana
Basu voted her shares to adopt our Amended 2004 Stock Option Plan ("Option
Plan"). Pursuant to the Option Plan, Ms. Basu is eligible to receive
1,250,000 shares of our common stock in connection with that Option
Plan.
Other
than as noted above, none of the directors, executive officers or any member of
the immediate family of any director or executive officer has been indebted to
us since its inception. We have not and do not intend to enter into any
additional transactions with our management or any nominees for such positions.
We have not and do not intend to enter into any transactions with our beneficial
owners.
(a)
Exhibits:
|
|
DESCRIPTION
|
|
|
|
31.1
|
|
Rule
13a-14(a)/15d-14(a) Certification
|
|
|
|
32.1
|
|
Certification
under Section 906 of the Sarbanes-Oxley Act (18 U.S.C. Section
1350)
|
(b)
Reports on Form 8-K
The
Company filed no Reports on Form 8-K during the fiscal quarter ended December
31, 2006.
|
PRINCIPAL
ACCOUNTANT FEES AND SERVICES
|
The
following table sets forth fees billed to us by our independent auditors for the
year ended December 31, 2007 and December 31, 2006 for (i) services rendered for
the audit of our annual financial statements and the review of our quarterly
financial statements, (ii) services rendered that are reasonably related to the
performance of the audit or review of our financial statements that are not
reported as Audit Fees, and (iii) services rendered in connection with tax
preparation, compliance, advice and assistance.
|
|
2007
|
|
|
2006
|
|
|
|
|
|
|
|
|
Audit
fees
|
|
$ |
10,000 |
|
|
$ |
22,500 |
|
Audit-related
fees
|
|
|
3,000 |
|
|
|
13,190 |
|
Tax
fees
|
|
|
|
|
|
|
- |
|
All
other fees
|
|
|
500 |
|
|
|
500 |
|
|
|
|
|
|
|
|
|
|
Total
fees
|
|
$ |
13,800 |
|
|
$ |
36,190 |
|
SIGNATURES
In
accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused
this report to be signed on its behalf by the undersigned, thereto duly
authorized.
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
/s/ Chandana Basu
|
|
Chief
Executive Officer, President
|
|
November
29, 2008
|
Chandana
Basu
|
|
and
Chief Financial Officer
|
|
|
In
accordance with the Exchange Act, this report has been signed below by the
following persons on behalf of the registrant and in the capacities and on the
dates indicated.
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
/s/ Chandana Basu
|
|
Chief
Executive Officer and
|
|
November
29, 2008
|
Chandana
Basu
|
|
President
|
|
|
|
|
|
|
|
/s/ Chandana Basu
|
|
Secretary/Treasurer
|
|
|
Chandana
Basu
|
|
Chief
Financial Officer
|
|
November
29, 2008
|